ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Long-Term Safety and Tolerability Study of NKTR-181 in Subjects With Chronic Low Back Pain or Chronic Non-Cancer Pain

ClinicalTrials.gov ID: NCT02367820

Public ClinicalTrials.gov record NCT02367820. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 10:27 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Multicenter, Open-Label, 52-Week Study To Evaluate the Long-Term Safety and Tolerability of NKTR-181 in Subjects With Moderate to Severe Chronic Low Back Pain or Chronic Non-Cancer Pain

Study identification

NCT ID
NCT02367820
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Nektar Therapeutics
Industry
Enrollment
638 participants

Conditions and interventions

Interventions

  • NKTR-181 BID tablets Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 13, 2015
Primary completion
Nov 30, 2017
Completion
Dec 31, 2017
Last update posted
Jun 21, 2021

2015 – 2018

United States locations

U.S. sites
56
U.S. states
27
U.S. cities
53
Facility City State ZIP Site status
Investigator Site - Saraland Saraland Alabama 36571
Investigator Site - Phoenix Phoenix Arizona 85023
Investigator Site - Tempe Tempe Arizona 85283
Investigator Site - Little Rock Little Rock Arkansas 72211
Investigator Site - Stamford Stamford Connecticut 06905
Investigator Site - Clearwater Clearwater Florida 33765
Investigator Site - Fort Lauderdale Fort Lauderdale Florida 33312
Investigator Site - Fort Myers Fort Myers Florida 33912
Investigator Site - Jacksonville Jacksonville Florida 32257
Investigator Site - Orlando Orlando Florida 32806
Investigator Site - Ormond Beach Ormond Beach Florida 32174
Investigator Site - Plantation Plantation Florida 33324
Investigator Site - Tampa Tampa Florida 33603
Investigator Site - West Palm Beach West Palm Beach Florida 33409
Investigator Site - Atlanta Atlanta Georgia 30338
Investigator Site - Blue Ridge Blue Ridge Georgia 30513
Investigator Site - Marietta Marietta Georgia 30060
Investigator Site - Norcross Norcross Georgia 30092
Investigator Site - Gurnee Gurnee Illinois 60031
Investigator Site - West Des Moines West Des Moines Iowa 50265
Investigator Site - Wichita Wichita Kansas 67207
Investigator Site - Louisville Louisville Kentucky 40213
Investigator Site - Bossier Bossier City Louisiana 71111
Investigator Site - New Orleans New Orleans Louisiana 70115
Investigator Site - Shreveport Shreveport Louisiana 71105
Investigator Site - Bay City Bay City Michigan 48706
Investigator Site - Pinconning Pinconning Michigan 48706
Investigator Site - Biloxi Biloxi Mississippi 39531
Investigator Site - Saint Louis 1 St Louis Missouri 63141
Investigator Site - Saint Louis 2 St Louis Missouri 63141
Investigator Site - Omaha Omaha Nebraska 68134
Investigator Site - Las Vegas 2 Las Vegas Nevada 89102
Investigator Site - Las Vegas 1 Las Vegas Nevada 89119
Investigator Site - Rochester Rochester New York 14642
Investigator Site - Williamsville Williamsville New York 14221
Investigator Site - Greensboro Greensboro North Carolina 27410
Investigator Site - Winston Salem Winston-Salem North Carolina 27103
Investigator Site - Fargo Fargo North Dakota 58104
Investigator Site - Beavercreek Beavercreek Ohio 45432
Investigator Site - Cincinnati 1 Cincinnati Ohio 45219
Investigator Site - Cincinnati 2 Cincinnati Ohio 45246
Investigator Site - Columbus Columbus Ohio 43235
Investigator Site - Duncansville Duncansville Pennsylvania 16635
Investigator Site - Jenkintown Jenkintown Pennsylvania 19046
Investigator Site - Dakota Dunes Dakota Dunes South Dakota 57047
Investigator Site - Rapid City Rapid City South Dakota 57702
Investigator Site - Memphis Memphis Tennessee 38119
Investigator Site - Arlington Arlington Texas 76012
Investigator Site - Austin Austin Texas 78731
Investigator Site - Killeen Killeen Texas 76543
Investigator Site - San Antonio San Antonio Texas 78229
Investigator Site - Salt Lake City Salt Lake City Utah 84124
Investigator Site - West Jordan West Jordan Utah 84088
Investigator Site - Midlothian Midlothian Virginia 23114
Investigator Site - Norfolk Norfolk Virginia 23507
Investigator Site - Kenosha Kenosha Wisconsin 53142

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02367820, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 21, 2021 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02367820 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →